相似文献
1
Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol.
Syst Rev. 2017 Dec 19;6(1):262. doi: 10.1186/s13643-017-0660-y.
2
Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.
Syst Rev. 2017 Nov 17;6(1):228. doi: 10.1186/s13643-017-0624-2.
3
Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
BMC Cancer. 2017 Nov 7;17(1):725. doi: 10.1186/s12885-017-3704-8.
4
Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
Int J Oncol. 2017 Mar;50(3):993-1001. doi: 10.3892/ijo.2017.3865. Epub 2017 Jan 30.
5
A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
J Transl Med. 2015 Apr 21;13:126. doi: 10.1186/s12967-015-0493-1.
6
A preliminary investigation of the relationship between circulating tumor cells and cancer stem cells in patients with breast cancer.
Cell Mol Biol (Noisy-le-grand). 2012 Feb 16;58 Suppl:OL1641-5.
7
A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay.
PLoS One. 2015 Oct 23;10(10):e0141166. doi: 10.1371/journal.pone.0141166. eCollection 2015.
8
Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer.
BMC Cancer. 2015 Mar 30;15:202. doi: 10.1186/s12885-015-1218-9.
9
Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
PLoS One. 2015 Apr 24;10(4):e0123976. doi: 10.1371/journal.pone.0123976. eCollection 2015.
10
Breast cancer stem cells: current advances and clinical implications.
Methods Mol Biol. 2015;1293:1-49. doi: 10.1007/978-1-4939-2519-3_1.
引用本文的文献
1
Biology of breast cancer brain metastases and novel therapies targeting the blood brain barrier: an updated review.
Med Oncol. 2023 May 18;40(6):181. doi: 10.1007/s12032-023-02047-0.
2
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.
Cancer Drug Resist. 2019 Mar 19;2(1):82-106. doi: 10.20517/cdr.2019.06. eCollection 2019.
3
Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients.
Curr Oncol. 2021 Sep 8;28(5):3507-3524. doi: 10.3390/curroncol28050302.
4
Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review.
Int J Mol Sci. 2020 Jul 24;21(15):5255. doi: 10.3390/ijms21155255.
5
HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer PI3K/AKT/mTOR signaling.
World J Stem Cells. 2020 Jan 26;12(1):87-99. doi: 10.4252/wjsc.v12.i1.87.
6
[Isolation of cancer stem cells and the establishment of a H O -resistant cancer stem cell model].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019 Nov 15;33(11):1433-1438. doi: 10.7507/1002-1892.201809014.
7
Liquid Biopsy in Oligometastatic Prostate Cancer-A Biologist's Point of View.
Front Oncol. 2019 Aug 14;9:775. doi: 10.3389/fonc.2019.00775. eCollection 2019.
8
Prognostic Significance of , , , and Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients.
Cells. 2019 Jun 29;8(7):652. doi: 10.3390/cells8070652.
9
Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance.
Cancers (Basel). 2018 Dec 3;10(12):482. doi: 10.3390/cancers10120482.
本文引用的文献
1
Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma.
Hepatol Int. 2014 Jul;8(3):321-9. doi: 10.1007/s12072-014-9539-3. Epub 2014 Jun 3.
2
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer.
Breast Cancer Res. 2015 Mar 4;17(1):31. doi: 10.1186/s13058-015-0539-6.
3
Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
Curr Cancer Drug Targets. 2015;15(3):256-69. doi: 10.2174/1568009615666150211102503.
4
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
Syst Rev. 2015 Jan 1;4(1):1. doi: 10.1186/2046-4053-4-1.
5
The prevalence of type 2 diabetes mellitus among older people in Africa: a systematic review study protocol.
BMJ Open. 2014 Jun 17;4(6):e004747. doi: 10.1136/bmjopen-2013-004747.
6
STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
Stem Cells. 2014 Oct;32(10):2571-82. doi: 10.1002/stem.1752.
7
Lack of correlation of stem cell markers in breast cancer stem cells.
Br J Cancer. 2014 Apr 15;110(8):2063-71. doi: 10.1038/bjc.2014.105. Epub 2014 Feb 27.
8
Circulating cancer stem cells: a novel prognostic predictor of hepatocellular carcinoma.
Hepatobiliary Surg Nutr. 2013 Feb;2(1):4-6. doi: 10.3978/j.issn.2304-3881.2012.09.02.
9
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Stem Cell Reports. 2013 Dec 27;2(1):78-91. doi: 10.1016/j.stemcr.2013.11.009. eCollection 2014 Jan 14.
10
Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.
Breast Cancer Res. 2013;15(5):R77. doi: 10.1186/bcr3471.
Zotero 插件